Immunyfit Healthtech appears to be a legitimate early-stage startup (incorporated in India, TiE50 award recognition) addressing a significant problem in autoimmune care using 'digital twin' technology. However, the submission itself contains demonstrably false and hyperbolic claims (e.g., 'most people have used my product', 'audience reach: everyone') which severely damages credibility. While the underlying project has scientific merit and verifiable early traction, the poor quality of the response and unrealistic metrics limit the score significantly relative to the established calibration baseline.
Ready to Compete for $150k+ in Prizes?
Move this data into a HackerNoon blog draft to become eligible for your share of $150k+ in cash and software prizes
Score Breakdown
Project Details
Algorithm Insights
Recommendations to Increase Usefulness Score
Document User Growth
Provide specific metrics on user acquisition and retention rates
Showcase Revenue Model
Detail sustainable monetization strategy and current revenue streams
Expand Evidence Base
Include testimonials, case studies, and third-party validation
Technical Roadmap
Share development milestones and feature completion timeline